RYAM

Rating neutralAI Memo

Rayonier Advanced Materials

As of 2026-04-15/Confidence medium/Horizon 6‑12m

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-04-15 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

neutral

Confidence

medium

Horizon

6‑12m

Key catalyst

May 13 annual meeting and leadership reset checkpoint • 2026-05-13

Expected move: +15%

Biggest risk

The bearish read is that FY2025 already showed how thin the margin for error is: negative free cash flow, 3.9x secured leverage, pressure in paperboard and high-yield pulp, and now a fresh Jesup disruption. If pricing gains come with volume giveback or operational hiccups linger, the stock can de-rate despite the turnaround narrative.

Invalidation

Break below $7 or thesis failure.

What would change my mind?

The bullish read is that 2025 marked the trough: Cellulose Specialties price actions held, Temiscaming suspension lowered costs, the Board and new CEO have sharpened the plan around EBITDA and free cash flow, and even modest success on pricing, working capital and capex could create meaningful equity torque from a small-cap, leveraged base.

Research note

Recommendation

neutral

Confidence

medium

As of

2026-04-15

Base target

$10

p=45%

Bull target

$13

p=25%

Bear target

p=30%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Jesup line restart after April fire
2026 free-cash-flow recovery must validate the reset
Biomaterials pipeline remains option value, not core thesis yet

BearKey bullets

Cellulose Specialties pricing actions pressure volumes or customer ordering more than planned.
High-yield pulp demand stays weak, especially in China and export channels.
Jesup fire impacts last longer than management currently expects.

WatchKey bullets

May 13 annual meeting and leadership reset checkpoint

Summary

High-level snapshot

Recommendation

neutral

Model confidence

medium

Timeframe

6‑12m

Asset

Equity

Trigger

Base case: $10 (p=45%)

Bull/Bear spread: +49% / -20%

Vs latest close: Bull +49% · Base +15% · Bear -20%

Scenario probabilities

Bull Target: $13 (p=25%)Base Target: $10 (p=45%)Bear Target: $7 (p=30%)

Commentary

Net sentiment is cautious-to-neutral with a slight positive prior: RYAM has identifiable self-help levers and credible Board pressure on cash, but the evidence still supports a monitoring-style thesis rather than a high-conviction turnaround call.

As of 2026-04-15 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Jesup line restart after April fire
2026 free-cash-flow recovery must validate the reset
Biomaterials pipeline remains option value, not core thesis yet

Scenarios

Bull Target (Scenario probability)

$13 / p=25% prob

Base Target (Scenario probability)

$10 / p=45% prob

Bear Target (Scenario probability)

$7 / p=30% prob

Price $9 as of 2026-06-02

Nearest Scenario: Base (∆ 15%)

Targets vs latest close: Bull +49% · Base +15% · Bear -20%

Sentiment & Exposure

Sentiment unavailable: insufficient coverage

Events

Other notable items detected

EVENT2026-05-13
May 13 annual meeting and leadership reset checkpoint
RYAM's March 30, 2026 proxy said Scott M. Sutton became CEO effective January 2026, the Board expects improvement in operating reliability, cost performance and cash generation in 2026, and the annual incentive program is tied exclusively to EBITDA and free cash flow. The May 13, 2026 annual meeting is the next dated checkpoint for investors to assess whether that accountability reset is credible. [#IR-2026-03-30]
Prob 60.00% • Move 5.00% • Priced-in 45.00%

Short-term Catalysts

Next few weeks

Jesup line restart after April fire
2026-05-31
On April 5, 2026, RYAM said an isolated fire occurred during the Jesup annual outage, one production line was not operating, but the company did not then expect a material supply impact. A clean restart would remove a fresh overhang; a longer disruption would matter for a business already trying to restore cash generation. [#PR-2026-04-05]
Prob 55% • Move 4% • Priced-in 50%

Long-term Catalysts

Months to a year

2026 free-cash-flow recovery must validate the reset
2027-04-15
Fourth-quarter results showed FY2025 adjusted EBITDA of $133 million, negative adjusted free cash flow of $88 million, $157 million of liquidity and a 3.9x net secured leverage ratio. Management said 2026 priorities are positive free cash flow, value-based Cellulose Specialties pricing, tighter working capital and lower capex; if those levers translate into cash, equity can rerate, but failure would keep balance-sheet pressure central. [#8-K-2026-03-03][#10-K-2026-03-05][#PR-2026-03-03]
Prob 50% • Move 12% • Priced-in 35%
Biomaterials pipeline remains option value, not core thesis yet
2027-04-15
RYAM's prior primary-source updates said it secured €67 million of green capital, aims for over $80 million of proportional Biomaterials EBITDA, and is advancing bioethanol, prebiotics and SAF-related projects, including GranBio due diligence work at Jesup. That upside still needs permitting, commercial conversion and execution proof, so it supports optionality more than near-term underwriting. [#10-Q-2025-11-05][#PR-2025-11-04][#PR-2025-07-31]
Prob 30% • Move 15% • Priced-in 20%

Risks

Cellulose Specialties pricing actions pressure volumes or customer ordering more than planned.
High-yield pulp demand stays weak, especially in China and export channels.
Jesup fire impacts last longer than management currently expects.
Leadership transition fails to translate into better operating execution.
Leverage and liquidity leave limited room for another year of poor cash conversion.
Paperboard remains under pressure from new U.S. capacity.

Peers

Symbol	Summary
PACK	Ranpak is the closest name in the provided peer set because of paper/packaging exposure, but it is still an imperfect comp because RYAM's value is driven far more by cellulose specialties, biomaterials optionality and leverage-sensitive cash conversion.
ASIX	AdvanSix is a loose process-materials comp for cyclical margin recovery and cost discipline, but end markets and product mix differ materially; use mainly as a cash-generation and execution comparator, not a direct valuation peer.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-04-15

AI Stock Memo: RYAM - Rayonier Advanced Materials - RankAlpha